Skip to content
healthcare.dev

BAT

NDC 60492-0075, Botulism Antitoxin Heptavalent, liquid, from Emergent BioSolutions Canada Inc.

Product NDC
60492-0075
Status
Listed
Labeler
Emergent BioSolutions Canada Inc
Dosage form
LIQUID
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125462
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0075 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB24500 [iU]/10mL
  • EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB23300 [iU]/10mL
  • EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB23000 [iU]/10mL
  • EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2600 [iU]/10mL
  • EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB25100 [iU]/10mL
  • EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB23000 [iU]/10mL
  • EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2600 [iU]/10mL
Package NDCNDC-11Package
60492-0075-2604920075026 VIAL, GLASS in 1 CARTON (60492-0075-2) / 50 mL in 1 VIAL, GLASS (60492-0075-1)
60492-0075-4604920075041 VIAL, GLASS in 1 CARTON (60492-0075-4) / 50 mL in 1 VIAL, GLASS (60492-0075-1)

Linked data

RxNorm, label and prices

Use it

Look up 60492-0075 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0075 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60492-0075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.